Rs150 per Covaxin dose to Centre not sustainable in the long run: Bharat Biotech

Share
AuthorPosted at
A higher price in private markets is required to offset part of the costs.

from India Infoline News Service https://ift.tt/3zwwVC7
Post a Comment
Labels

Comments